Toronto Dominion Bank boosted its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 173.5% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 32,410 shares of the pharmacy operator’s stock after buying an additional 20,561 shares during the period. Toronto Dominion Bank’s holdings in Walgreens Boots Alliance were worth $2,614,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nordea Investment Management AB boosted its stake in Walgreens Boots Alliance by 4,480.8% in the third quarter. Nordea Investment Management AB now owns 7,453,892 shares of the pharmacy operator’s stock valued at $600,933,000 after buying an additional 7,291,172 shares in the last quarter. Boston Partners boosted its stake in Walgreens Boots Alliance by 5,790.4% in the second quarter. Boston Partners now owns 3,158,410 shares of the pharmacy operator’s stock valued at $263,001,000 after buying an additional 3,104,790 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its stake in Walgreens Boots Alliance by 60.1% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,525,003 shares of the pharmacy operator’s stock valued at $626,607,000 after buying an additional 2,825,700 shares in the last quarter. Capital World Investors boosted its stake in Walgreens Boots Alliance by 11.5% in the second quarter. Capital World Investors now owns 19,625,115 shares of the pharmacy operator’s stock valued at $1,634,183,000 after buying an additional 2,028,252 shares in the last quarter. Finally, Prudential Financial Inc. boosted its stake in Walgreens Boots Alliance by 175.9% in the second quarter. Prudential Financial Inc. now owns 3,076,394 shares of the pharmacy operator’s stock valued at $256,171,000 after buying an additional 1,961,497 shares in the last quarter. 58.93% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 1.09% during mid-day trading on Monday, reaching $85.35. 3,956,847 shares of the company’s stock were exchanged. The stock has a market cap of $92.46 billion, a P/E ratio of 22.34 and a beta of 1.19. Walgreens Boots Alliance Inc. has a 52 week low of $71.50 and a 52 week high of $87.05. The stock has a 50-day moving average price of $81.44 and a 200-day moving average price of $81.10.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The business earned $28.60 billion during the quarter, compared to the consensus estimate of $29.06 billion. During the same period in the prior year, the company earned $0.88 EPS. Walgreens Boots Alliance’s revenue for the quarter was up .4% on a year-over-year basis. On average, analysts forecast that Walgreens Boots Alliance Inc. will post $5.01 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Investors of record on Thursday, November 17th will be given a dividend of $0.375 per share. The ex-dividend date is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.78%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.27%.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2016/11/28/toronto-dominion-bank-purchases-20561-shares-of-walgreens-boots-alliance-inc-wba.html.

Several analysts have weighed in on the stock. Deutsche Bank AG reiterated a “buy” rating and set a $88.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, November 10th. Leerink Swann set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, November 8th. Jefferies Group set a $95.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, November 8th. Wells Fargo & Co. assumed coverage on shares of Walgreens Boots Alliance in a research note on Monday, October 31st. They set an “outperform” rating for the company. Finally, Barclays PLC set a $79.00 target price on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Friday, October 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $90.30.

In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the company’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $85.00, for a total value of $2,039,660.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,067 shares of the company’s stock in a transaction dated Wednesday, November 2nd. The stock was sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the transaction, the director now directly owns 24,623 shares of the company’s stock, valued at approximately $2,001,849.90. The disclosure for this sale can be found here. Corporate insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.